GlassScriptPhysician profile
Jonathan Woody
NPI 1770570871
$8,703.13
in general payments reported to CMS, 2019-2025
40 companies · $1,821 in 2025
The $1,821 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,839 · 2020: $961 · 2021: $777 · 2022: $1,029 · 2023: $1,524 · 2024: $752 · 2025: $1,821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,061 · Travel and Lodging: $36.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,061.02 |
| Travel and Lodging | $36.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,216.85 | 2021-2025 | Endurant Iis, Valiant Captivia, Heli-Fx Endoanchor System |
| W. L. Gore & Associates, INC. | $1,160.01 | 2019-2025 | Gore Tag Conformable Thoracic Stent Graft, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Endoprosthesis With Heparin |
| Endologix LLC | $848.23 | 2019-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Penumbra, INC. | $740.41 | 2022-2025 | Penumbra System, Indigo System, Ruby Coil |
| Boston Scientific Corporation | $716.07 | 2019-2025 | Enroute Transcarotid Neuroprotection System, General - Therapies, Varithena Administration Pack |
| Medtronic Vascular, INC. | $589.62 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $390.38 | 2020-2022 | |
| Angiodynamics, INC. | $314.52 | 2020-2024 | Auryon Laser System 100-120 Vac |
| Organogenesis INC. | $246.52 | 2020-2023 | Puraply |
| Lemaitre Vascular, INC. | $193.13 | 2019-2024 | Artegraft Vascular Graft |
| Tactile Systems Technology INC | $176.38 | 2020-2022 | |
| Kerecis Limited | $161.41 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Silk Road Medical, INC. | $153.79 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Polynovo North America LLC | $130.00 | 2021-2023 | |
| Biocomposites INC | $118.89 | 2021 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $78.25 | 2019-2022 | |
| Artivion, INC. | $46.83 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $45.75 | 2020-2023 | |
| Cardiva Medical, INC. | $44.82 | 2021-2022 | |
| Apollo Endosurgery US INC | $36.74 | 2022 | |
| Imperative Care, INC | $28.08 | 2024 | Symphony Catheter |
| Cagent Vascular INC | $23.70 | 2025 | Serrantor |
| Humacyte Global, INC. | $20.47 | 2025 | Symvess |
| Portola Pharmaceuticals, LLC | $18.69 | 2019 | |
| Inspiremd LTD | $18.52 | 2025 | Cguard Prime Carotid Stent System |
| Smith+Nephew, INC. | $17.27 | 2023 | Stravix, Grafix |
| Siemens Medical Solutions USA, INC. | $16.30 | 2022 | |
| Inari Medical, INC. | $15.57 | 2022 | |
| Argon Medical Devices, INC. | $15.28 | 2024 | Clot Management |
| Baxter Healthcare | $14.71 | 2023 | Floseal |
| Medistim USA, INC. | $14.50 | 2023 | Miraq |
| Veryan Medical Incorporated | $13.81 | 2022 | |
| Convatec INC. | $12.22 | 2021 | |
| Merck Sharp & Dohme LLC | $12.20 | 2020 | |
| Abbott Laboratories | $11.80 | 2021 | |
| Medline Industries LP | $11.69 | 2019 | |
| Bard Peripheral Vascular, INC. | $10.81 | 2021 | |
| Cardiovascular Systems INC. | $8.97 | 2020 | |
| Flowphysix INC | $5.69 | 2025 | Flowrunner |
| Cashflow Solutions, LLC | $4.25 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Woody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.